Convergent Genomics Overview
- Year Founded
-
2014
- Status
-
Acquired/Merged
- Employees
-
26
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$150M
Convergent Genomics General Information
Description
Developer of a liquid biopsy sequencing platform designed to improve cancer care. The company's platform leverages data analytics to introduce and utilize new paradigms to generate actionable insights regarding clinical diagnosis and prognosis, enabling medical practitioners to predict drug response and develop diagnostics for minimally invasive and early detection of cancer.
Contact Information
Website
www.convergentgenomics.com(Operating Subsidiary)
Corporate Office
- 425 Eccles Avenue
- San Francisco, CA 94080
- United States
Corporate Office
- 425 Eccles Avenue
- San Francisco, CA 94080
- United States
Convergent Genomics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Merger/Acquisition | 14-Sep-2026 | $150M | Completed | Generating Revenue | ||
| 7. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 6. Grant | 01-Jan-2020 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series A) | 01-Jan-2018 | Completed | Generating Revenue | |||
| 4. Grant | 01-Jan-2016 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Jan-2016 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 05-Sep-2015 | Completed | Generating Revenue | |||
| 1. University Spin-Out | 01-Jan-2015 | Completed | Generating Revenue |
Convergent Genomics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
Convergent Genomics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Convergent Genomics Patents
Convergent Genomics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-11421217-B1 | Methods and compositions for collection and preservation of biologicals | Active | 07-Apr-2021 | ||
| US-12098364-B2 | Methods and compositions for collection and preservation of biologicals | Active | 07-Apr-2021 | ||
| US-20220389405-A1 | Methods and compositions for collection and preservation of biologicals | Active | 07-Apr-2021 | ||
| WO-2022216865-A1 | Methods and compositions for collection and preservation of biologicals | Inactive | 07-Apr-2021 | ||
| EP-3976810-A1 | Methods and systems for urine-based detection of urologic conditions | Pending | 31-May-2019 | C12Q1/6886 |
Convergent Genomics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Convergent Genomics Former Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Civilization Ventures | Venture Capital | Minority | ||
| HBM Genomics | Venture Capital | Minority | ||
| Illumina Accelerator | Accelerator/Incubator | Minority | ||
| OHSU | University | |||
| Springboard Enterprises | Accelerator/Incubator | Minority |
Convergent Genomics FAQs
-
When was Convergent Genomics founded?
Convergent Genomics was founded in 2014.
-
Where is Convergent Genomics headquartered?
Convergent Genomics is headquartered in San Francisco, CA.
-
What is the size of Convergent Genomics?
Convergent Genomics has 26 total employees.
-
What industry is Convergent Genomics in?
Convergent Genomics’s primary industry is Diagnostic Equipment.
-
Is Convergent Genomics a private or public company?
Convergent Genomics is a Private company.
-
What is the current valuation of Convergent Genomics?
The current valuation of Convergent Genomics is .
-
What is Convergent Genomics’s current revenue?
The current revenue for Convergent Genomics is .
-
How much funding has Convergent Genomics raised over time?
Convergent Genomics has raised $13.6M.
-
Who are Convergent Genomics’s investors?
Civilization Ventures, HBM Genomics, Illumina Accelerator, OHSU, and Springboard Enterprises are 5 of 6 investors who have invested in Convergent Genomics.
-
When was Convergent Genomics acquired?
Convergent Genomics was acquired on 14-Sep-2026.
-
Who acquired Convergent Genomics?
Convergent Genomics was acquired by Veracyte.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
